Personalized Allergy Treatment and Research Platform

Publication ID: 24-11857623_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Personalized Allergy Treatment and Research Platform,” Published Technical Disclosure No. 24-11857623_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857623_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,623.

Summary of the Inventive Concept

A comprehensive system for personalized allergy treatment, prediction, and research, leveraging advanced computational models, machine learning, and crowdsourced data to revolutionize the field of allergy treatment and prevention.

Background and Problem Solved

The original pan-antiallergy vaccine patent, while a significant breakthrough, has limitations in terms of its broad, non-specific approach to treating allergies. The new inventive concept addresses these limitations by envisioning a next-generation platform that integrates personalized genetic information, advanced computational models, and real-time monitoring to provide tailored treatment and prevention strategies.

Detailed Description of the Inventive Concept

The inventive concept comprises a system for personalized allergy treatment, comprising a database of genetic information, a module for identifying specific IgE motifs associated with an individual's allergies, and a module for generating a customized protein construct based on the identified motifs. Additionally, the system includes a method for predicting the efficacy of an allergy vaccine, a device for real-time monitoring of IgE levels, a computer-implemented method for designing novel protein scaffolds, and a system for crowdsourced allergy research. These components work in concert to provide a comprehensive platform for allergy treatment, prevention, and research.

Novelty and Inventive Step

The new claims introduce a paradigm shift in allergy treatment by leveraging advanced computational models, machine learning, and crowdsourced data to provide personalized, tailored solutions. The inventive concept's novelty lies in its integration of these components to create a comprehensive platform that addresses the limitations of the original pan-antiallergy vaccine patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include variations in the computational models used, the types of data collected and shared, and the specific applications of the platform in different industries, such as pharmaceuticals, biotechnology, and healthcare.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the allergy treatment and prevention market, with potential applications in pharmaceuticals, biotechnology, and healthcare. The platform's ability to provide personalized, tailored solutions could revolutionize the field and create new opportunities for companies and researchers.

CPC Classifications

SectionClassGroup
A A61 A61K39/395
A A61 A61K2039/544
A A61 A61K2039/555

Original Patent Information

Patent NumberUS 11,857,623
TitlePan-antiallergy vaccine
Assignee(s)King Abdulaziz University